Fisher Asset Management LLC Has $3.78 Million Holdings in The Chemours Company (NYSE:CC)

Fisher Asset Management LLC cut its stake in The Chemours Company (NYSE:CC - Free Report) by 22.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 119,708 shares of the specialty chemicals company's stock after selling 34,065 shares during the period. Fisher Asset Management LLC owned 0.08% of Chemours worth $3,776,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in CC. Hexagon Capital Partners LLC purchased a new stake in Chemours in the fourth quarter valued at approximately $25,000. Morton Brown Family Wealth LLC purchased a new position in shares of Chemours during the fourth quarter worth $35,000. Anchor Investment Management LLC acquired a new position in Chemours during the fourth quarter valued at $56,000. Geneos Wealth Management Inc. boosted its holdings in Chemours by 116.4% in the fourth quarter. Geneos Wealth Management Inc. now owns 1,859 shares of the specialty chemicals company's stock valued at $59,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Bfsg LLC acquired a new stake in Chemours during the 4th quarter worth about $62,000. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. UBS Group lifted their target price on shares of Chemours from $21.00 to $28.00 and gave the company a "neutral" rating in a report on Tuesday, April 2nd. Barclays decreased their target price on Chemours from $32.00 to $30.00 and set an "equal weight" rating on the stock in a research report on Tuesday, April 2nd. Finally, BMO Capital Markets upgraded shares of Chemours from an "underperform" rating to an "outperform" rating and boosted their price target for the stock from $19.00 to $34.00 in a research report on Tuesday, April 9th. Seven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $31.63.


Get Our Latest Analysis on Chemours

Chemours Trading Down 1.7 %

CC traded down $0.47 during trading hours on Wednesday, reaching $27.50. The company's stock had a trading volume of 1,076,863 shares, compared to its average volume of 1,808,955. The business's 50-day moving average is $26.40 and its 200-day moving average is $27.88. The company has a debt-to-equity ratio of 5.26, a current ratio of 1.61 and a quick ratio of 0.99. The stock has a market cap of $4.09 billion, a PE ratio of -12.67 and a beta of 1.99. The Chemours Company has a fifty-two week low of $15.10 and a fifty-two week high of $39.05.

Chemours (NYSE:CC - Get Free Report) last issued its quarterly earnings data on Tuesday, April 30th. The specialty chemicals company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.07. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.35 billion. Chemours had a negative net margin of 5.51% and a positive return on equity of 46.67%. Chemours's revenue was down 12.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.98 EPS. As a group, equities research analysts predict that The Chemours Company will post 2.16 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.00 annualized dividend and a dividend yield of 3.64%. Chemours's dividend payout ratio is currently -46.08%.

Chemours Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Read More

Institutional Ownership by Quarter for Chemours (NYSE:CC)

→ 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad)

Should you invest $1,000 in Chemours right now?

Before you consider Chemours, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemours wasn't on the list.

While Chemours currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Featured Articles and Offers

Search Headlines: